12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide

C42H51BrN6O6S — CID 174175470

IUPAC12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide
SMILESCOc1cc2c(NC(C)c3cccc(Br)c3)nc(C)nc2cc1OCCCCCCCCCCCC(=O)NCc1scc2c1CN(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C42H51BrN6O6S/c1-26(28-14-13-15-29(43)20-28)45-40-30-21-35(54-3)36(22-33(30)46-27(2)47-40)55-19-12-10-8-6-4-5-7-9-11-16-38(50)44-23-37-31-24-49(42(53)32(31)25-56-37)34-17-18-39(51)48-41(34)52/h13-15,20-22,25-26,34H,4-12,16-19,23-24H2,1-3H3,(H,44,50)(H,45,46,47)(H,48,51,52)
InChIKeyDDCUVDJCHIUGKO-UHFFFAOYSA-N
MW847.88 g/mol
LogP8.30
Rot. Bonds20

About 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide

12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide (PubChem CID 174175470) has the molecular formula C42H51BrN6O6S and a molecular weight of 847.88 g/mol. Its IUPAC name is 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide.

Molecular Properties

Compound Name12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide
PubChem CID174175470
Molecular FormulaC42H51BrN6O6S
Molecular Weight847.88 g/mol
Exact Mass846.28
IUPAC Name12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide
SMILESCOc1cc2c(NC(C)c3cccc(Br)c3)nc(C)nc2cc1OCCCCCCCCCCCC(=O)NCc1scc2c1CN(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C42H51BrN6O6S/c1-26(28-14-13-15-29(43)20-28)45-40-30-21-35(54-3)36(22-33(30)46-27(2)47-40)55-19-12-10-8-6-4-5-7-9-11-16-38(50)44-23-37-31-24-49(42(53)32(31)25-56-37)34-17-18-39(51)48-41(34)52/h13-15,20-22,25-26,34H,4-12,16-19,23-24H2,1-3H3,(H,44,50)(H,45,46,47)(H,48,51,52)
InChIKeyDDCUVDJCHIUGKO-UHFFFAOYSA-N
XLogP8.30
TPSA151.85 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds20
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500847.88
LogP ≤ 58.30
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide?
The IUPAC name of 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide (CID 174175470) is 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide.
What is the SMILES notation for 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide?
The canonical SMILES for 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide is COc1cc2c(NC(C)c3cccc(Br)c3)nc(C)nc2cc1OCCCCCCCCCCCC(=O)NCc1scc2c1CN(C1CCC(=O)NC1=O)C2=O.
What is the InChIKey of 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide?
The InChIKey is DDCUVDJCHIUGKO-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H51BrN6O6S/c1-26(28-14-13-15-29(43)20-28)45-40-30-21-35(54-3)36(22-33(30)46-27(2)47-40)55-19-12-10-8-6-4-5-7-9-11-16-38(50)44-23-37-31-24-49(42(53)32(31)25-56-37)34-17-18-39(51)48-41(34)52/h13-15,20-22,25-26,34H,4-12,16-19,23-24H2,1-3H3,(H,44,50)(H,45,46,47)(H,48,51,52).
What are the key properties of 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide?
12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide has a molecular weight of 847.88 g/mol, XLogP of 8.30, 20 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 12-[4-[1-(3-bromophenyl)ethylamino]-6-methoxy-2-methylquinazolin-7-yl]oxy-N-[[5-(2,6-dioxopiperidin-3-yl)-6-oxo-4H-thieno[3,4-c]pyrrol-3-yl]methyl]dodecanamide is sourced from PubChem (CID 174175470), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).